Cargando…
CD54-NOTCH1 axis controls tumor initiation and cancer stem cell functions in human prostate cancer
Cancer stem cells (CSCs) are considered one of the key contributors to chemoresistance and tumor recurrence. Therefore, the precise identification of reliable CSC markers and clarification of the intracellular signaling involved in CSCs remains a great challenge in fields relating to cancer biology....
Autores principales: | Li, Chong, Liu, Shengwu, Yan, Ruping, Han, Ning, Wong, Kwok-Kin, Li, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5196886/ https://www.ncbi.nlm.nih.gov/pubmed/28042317 http://dx.doi.org/10.7150/thno.16752 |
Ejemplares similares
-
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL
por: Piya, Sujan, et al.
Publicado: (2022) -
A YAP/TAZ-CD54 axis is required for CXCR2(−)CD44(−) tumor-specific neutrophils to suppress gastric cancer
por: Nie, Pingping, et al.
Publicado: (2022) -
Regulation of PCGEM1 by p54/nrb in prostate cancer
por: Ho, Tsui-Ting, et al.
Publicado: (2016) -
Heterogeneity of breast cancer stem cells as evidenced with Notch-dependent and Notch-independent populations
por: Wong, Nelson K Y, et al.
Publicado: (2012) -
Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer
por: Shen, Yongmei, et al.
Publicado: (2019)